Recent IMUX News
- Immunic Presents Key Vidofludimus Calcium Data at the 40th Congress of ECTRIMS, Highlighting Its Therapeutic Potential in Multiple Sclerosis • PR Newswire (US) • 09/18/2024 10:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/10/2024 08:05:53 PM
- Immunic Announces First Patient Enrolled in Investigator-Sponsored Phase 2 Clinical Trial of Vidofludimus Calcium in Patients with Post COVID Syndrome • PR Newswire (US) • 09/04/2024 10:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/03/2024 12:30:38 PM
- Immunic to Host Multiple Sclerosis R&D Day and Participate in Scientific and Investor Conferences in September • PR Newswire (US) • 08/28/2024 10:30:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 11:17:43 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 10:45:40 AM
- Immunic, Inc. Reports Second Quarter 2024 Financial Results and Provides Corporate Update • PR Newswire (US) • 08/08/2024 10:30:00 AM
- Immunic, Inc. to Announce Financial Results for the Second Quarter Ended June 30, 2024, and Provide Corporate Update • PR Newswire (US) • 08/01/2024 10:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/24/2024 08:11:28 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 07/24/2024 08:10:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/24/2024 10:40:20 AM
- Immunic, Inc. Strengthens Its Board of Directors with the Appointment of Experienced Pharmaceutical Executive Simona Skerjanec • PR Newswire (US) • 07/24/2024 10:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/12/2024 12:31:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/09/2024 10:40:33 AM
- Immunic Appoints Jason Tardio as Chief Operating Officer and President • PR Newswire (US) • 07/09/2024 10:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/12/2024 08:08:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/12/2024 08:07:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/12/2024 08:05:58 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 06/10/2024 08:05:34 PM
- Immunic to Participate in Industry and Scientific Conferences in June • PR Newswire (US) • 05/28/2024 10:30:00 AM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 05/24/2024 08:06:52 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/08/2024 11:20:20 AM
FEATURED Nightfood Signs Letter of Intent to Acquire Los Angeles Cooking School, Integrating Automation and Robotics with World-Class Culinary Training • Oct 1, 2024 8:30 AM
FEATURED ZenaTech, Inc. (NASDAQ: ZENA) To Commence Trading Today • Oct 1, 2024 7:00 AM
Integrated Ventures, Inc Reports Total 2024 Revenues Of $5,863,935 vs $3,862,849 for 2023. • INTV • Oct 1, 2024 9:00 AM
Element79 Gold Corp secures loi for launching tailings reprocessing business in Arequipa, Peru • ELMGF • Oct 1, 2024 6:38 AM
BARRON'S COVE to Premier at the Hamptons International Film Festival • APHP • Sep 30, 2024 2:56 PM
Lingerie Fighting Championships Signs Broadcast Deal With Maybacks Global Entertainment • BOTY • Sep 26, 2024 9:00 AM